Vigil Total Current Liabilities from 2010 to 2024

VIGL Stock  USD 3.05  0.01  0.33%   
Vigil Neuroscience Total Current Liabilities yearly trend continues to be quite stable with very little volatility. The value of Total Current Liabilities is projected to decrease to about 9.6 M. Total Current Liabilities is the total amount of liabilities that Vigil Neuroscience is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. View All Fundamentals
 
Total Current Liabilities  
First Reported
2010-12-31
Previous Quarter
11.7 M
Current Value
9.6 M
Quarterly Volatility
M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Vigil Neuroscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vigil Neuroscience's main balance sheet or income statement drivers, such as Depreciation And Amortization of 379.1 K, Interest Expense of 85.2 K or Selling General Administrative of 17.3 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.18. Vigil financial statements analysis is a perfect complement when working with Vigil Neuroscience Valuation or Volatility modules.
  
Check out the analysis of Vigil Neuroscience Correlation against competitors.
For more information on how to buy Vigil Stock please use our How to buy in Vigil Stock guide.

Latest Vigil Neuroscience's Total Current Liabilities Growth Pattern

Below is the plot of the Total Current Liabilities of Vigil Neuroscience over the last few years. Total Current Liabilities is an item on Vigil Neuroscience balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Vigil Neuroscience are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. It is the total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. Vigil Neuroscience's Total Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vigil Neuroscience's overall financial position and show how it may be relating to other accounts over time.
Total Current Liabilities10 Years Trend
Slightly volatile
   Total Current Liabilities   
       Timeline  

Vigil Total Current Liabilities Regression Statistics

Arithmetic Mean4,292,165
Geometric Mean3,112,180
Coefficient Of Variation92.54
Mean Deviation3,369,175
Median1,995,000
Standard Deviation3,971,843
Sample Variance15.8T
Range9.7M
R-Value0.76
Mean Square Error7.2T
R-Squared0.58
Significance0.001
Slope675,873
Total Sum of Squares220.9T

Vigil Total Current Liabilities History

20249.6 M
202311.7 M
202211.3 M
20219.9 M

About Vigil Neuroscience Financial Statements

Vigil Neuroscience investors utilize fundamental indicators, such as Total Current Liabilities, to predict how Vigil Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Total Current Liabilities11.7 M9.6 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Vigil Neuroscience is a strong investment it is important to analyze Vigil Neuroscience's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vigil Neuroscience's future performance. For an informed investment choice regarding Vigil Stock, refer to the following important reports:
Check out the analysis of Vigil Neuroscience Correlation against competitors.
For more information on how to buy Vigil Stock please use our How to buy in Vigil Stock guide.
You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vigil Neuroscience. If investors know Vigil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vigil Neuroscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.07)
Return On Assets
(0.40)
Return On Equity
(0.70)
The market value of Vigil Neuroscience is measured differently than its book value, which is the value of Vigil that is recorded on the company's balance sheet. Investors also form their own opinion of Vigil Neuroscience's value that differs from its market value or its book value, called intrinsic value, which is Vigil Neuroscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vigil Neuroscience's market value can be influenced by many factors that don't directly affect Vigil Neuroscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vigil Neuroscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vigil Neuroscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vigil Neuroscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.